🇺🇸 FDA
Pipeline program

Capivasertib, Placebo for capivasertib film-coated tablet for oral use, ABIRATERONE ACETATE, Capivasertib

D361BC00001

Phase 3 small_molecule active

Quick answer

Capivasertib, Placebo for capivasertib film-coated tablet for oral use, ABIRATERONE ACETATE, Capivasertib for Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials